• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    3/9/23 1:10:32 PM ET
    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Specialty Stores
    Consumer Discretionary
    Get the next $AKBA alert in real time by email

    Gainers

    • Ocean Biomedical, Inc. (NASDAQ:OCEA) shares climbed 62.3% to $7.61 after the company shared detailed research data on anti-tumor pathway discoveries and their potential for treatment of non-small cell lung cancer, metastatic melanoma, and glioblastoma by Scientific Co-founder, Dr. Jack A. Elias, MD.
    • Toro Corp. (NASDAQ:TORO) shares climbed 53.2% to $5.90.
    • Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 36% to $2.21. EF Hutton initiated coverage on Unicycive Therapeutics with a Buy rating and announced a price target of $5.
    • Holley Inc. (NYSE:HLLY) surged 32% to $2.6099 following Q4 results.
    • Intuitive Machines, Inc. (NASDAQ:LUNR) rose 30.3% to $13.37
    • Solo Brands, Inc. (NYSE:DTC) gained 28.1% to $5.15 after the company announced better-than-expected Q4 results.
    • Biophytis S.A. (NASDAQ:BPTS) rose 27.9% to $0.6460 after the company said it will present results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 at the European Respiratory Society 2023 21st Lung Science Conference taking place in Estoril, Portuga.
    • Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) shares rose 26.3% to $0.6703. Neoleukin Therapeutics engaged SVB Securities to assist in reviewing strategic alternatives. The company also approved a further corporate restructuring to preserve cash, including reducing its workforce by approximately 70%.
    • Asana, Inc. (NYSE:ASAN) rose 26.3% to $22.48 as the company reported better-than-expected Q4 results and issued strong forecast for the current quarter.
    • Build-A-Bear Workshop, Inc. (NYSE:BBW) gained 22.5% to $25.23 after the company reported fourth-quarter FY22 sales growth of 11.6% year-on-year to $145.11 million, beating the consensus of $137.54 million.
    • KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) jumped 21.4% to $16.48 following Q4 results.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) rose 19.8% to $4.36 after gaining over 9% on Wednesday.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares rose 19.4% to $1.2425 after the company issued regulatory update on IV Tramadol and other corporate updates.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) gained 18.6% to $0.7899. Kaival Brands signed an agreement with a prominent national broker, increasing potential distribution by upwards of 40,000 retail stores.
    • Townsquare Media, Inc. (NYSE:TSQ) gained 18% to $8.56 following strong quarterly results.
    • Paysafe Limited (NYSE:PSFE) jumped 15.7% to $23.49. Paysafe reported a fourth-quarter FY22 revenue growth of 3% year-on-year to $383.6 million, beating the consensus of $376.1 million.
    • Stabilis Solutions, Inc. (NASDAQ:SLNG) gained 15.6% to $3.5605 after posting a profit for the fourth quarter.
    • Duluth Holdings Inc. (NASDAQ:DLTH) jumped 14.7% to $7.09 following upbeat quarterly earnings.
    • Finch Therapeutics Group, Inc. (NASDAQ:FNCH) gained 14.6% to $0.4599.
    • FuelCell Energy, Inc. (NASDAQ:FCEL) jumped 13.9% to $3.76 after the company reported better-than-expected Q1 EPS and sales results.
    • Versus Systems Inc. (NASDAQ:VS) shares rose 13.4% to $0.6799. Versus Systems, last month, announced a $2.25 million registered direct offering.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) gained 13% to $6.74 following strong quarterly sales.
    • Miller Industries, Inc. (NYSE:MLR) jumped 11.8% to $30.40 after reporting a rise in Q4 earnings.
    • Troika Media Group, Inc. (NASDAQ:TRKA) rose 11.4% to $0.3820 after dipping around 39% on Wednesday. Troika Media recently reported revenue of $187.91 million for the six months ended FY22, up from $15.34 million a year ago.
    • Sovos Brands, Inc. (NASDAQ:SOVO) gained 11.4% to $14.66 after the company reported better-than-expected Q4 results and issued strong FY23 guidance.
    • Docebo Inc. (NASDAQ:DCBO) gained 10.2% to $39.41 following upbeat quarterly earnings.
    • Nuvei Corporation (NASDAQ:NVEI) jumped 8.4% to $39.47. Credit Suisse upgraded Nuvei from Neutral to Outperform and raised the price target from $37 to $45.

    Losers

    • InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares dipped 48.2% to $1.0873 after the company announced topline data from its INSPIRE 2.0 study in acute spinal cord injury, in which the primary endpoint was not met.
    • SVB Financial Group (NASDAQ:SIVB) fell 37.4% to $167.36 after the parent of Silicon Valley Bank announced proposed offerings of common stock and convertible preferred stock.
    • Silvergate Capital Corporation (NYSE:SI) shares fell 28.7% to $3.60 after the company announced it will wind down operations and voluntarily liquidate Silvergate Bank.
    • Akebia Therapeutics, Inc. (NASDAQ:AKBA) dipped 23% to $0.7931 following Q4 results.
    • Titan Medical Inc. (NASDAQ:TMDI) fell 22.2% to $0.1479 after the company reported decision of Nasdaq Hearings Panel to delist common shares.
    • Stagwell Inc. (NASDAQ:STGW) dropped 20.9% to $6.95 after the company announced the launch of a 16 million share secondary offering of common stock.
    • Predictive Oncology Inc. (NASDAQ:POAI) fell 18% to $0.3361.
    • Fulcrum Therapeutics, Inc. (NASDAQ:FULC) fell 17.3% to $5.18. Fulcrum Therapeutics posted a Q4 loss of $0.50 per share.
    • PacWest Bancorp (NASDAQ:PACW) dipped 16.9% to $22.17.
    • VSE Corporation (NASDAQ:VSEC) fell 16.7% to $47.17 following weak quarterly results.
    • Elys Game Technology, Corp. (NASDAQ:ELYS) tumbled 16.7% to $0.5241.
    • John Wiley & Sons, Inc. (NYSE:WLY) fell 15.7% to $36.65 after posting downbeat quarterly results.
    • Arhaus, Inc. (NASDAQ:ARHS) dipped 14.7% to $10.92 following Q4 results.
    • Kronos Worldwide, Inc. (NYSE:KRO) dropped 14.6% to $9.32 following Q4 results.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares fell 14.5% to $0.1650 after dropping 5% on Wednesday.
    • Helen of Troy Limited (NASDAQ:HELE) dropped 10.3% to $102.63. Helen of Troy announced resignation of CFO Matt Osberg.
    • Exela Technologies, Inc. (NASDAQ:XELA) fell 9.3% to $0.0624 after gaining 12% on Wednesday.
    • JD.com, Inc. (NASDAQ:JD) fell 8.8% to $42.87 after the company Q4 financial results.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) fell 8.5% to $0.2633. Borqs Technologies shares gained 17% on Wednesday after the company announced a contract to develop and manufacture an Android 5G rugged waterproof handheld device.
    • MongoDB, Inc. (NASDAQ:MDB) shares dropped 7.1% to $212.89 after the company issued weak revenue guidance.
    • Etsy, Inc. (NASDAQ:ETSY) fell 4% to $108.62 after Jefferies downgraded the stock from Buy to Underperform and lowered the price target from $150 to $85.

    Now Read This: Top 5 Consumer Staples Stocks That Could Lead To Your Biggest Gains In March

    Get the next $AKBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKBA
    $ARHS
    $ASAN
    $ASRT

    CompanyDatePrice TargetRatingAnalyst
    Etsy Inc.
    $ETSY
    2/20/2026$72.00Equal Weight → Overweight
    Barclays
    Asana Inc.
    $ASAN
    1/15/2026$16.00Neutral → Buy
    Citigroup
    Fulcrum Therapeutics Inc.
    $FULC
    1/12/2026$20.00Overweight
    Analyst
    Intuitive Machines Inc.
    $LUNR
    1/9/2026$20.00Buy → Hold
    Stifel
    MongoDB Inc.
    $MDB
    1/6/2026$480.00 → $500.00Buy
    Needham
    Intuitive Machines Inc.
    $LUNR
    12/19/2025$20.00Overweight
    KeyBanc Capital Markets
    FuelCell Energy Inc.
    $FCEL
    12/19/2025$7.00 → $9.00Hold
    TD Cowen
    Asana Inc.
    $ASAN
    12/17/2025Neutral
    BTIG Research
    More analyst ratings

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, General Counsel Schlessinger Sam covered exercise/tax liability with 1,239 shares and converted options into 2,778 shares, increasing direct ownership by 12% to 14,105 units (SEC Form 4)

    4 - Assertio Holdings, Inc. (0001808665) (Issuer)

    2/20/26 6:01:14 PM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and COO Schwichtenberg Paul converted options into 2,778 shares and covered exercise/tax liability with 1,377 shares, increasing direct ownership by 12% to 13,410 units (SEC Form 4)

    4 - Assertio Holdings, Inc. (0001808665) (Issuer)

    2/20/26 6:00:44 PM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP and CFO Patel Ajay converted options into 2,778 shares and covered exercise/tax liability with 1,377 shares, increasing direct ownership by 10% to 15,365 units (SEC Form 4)

    4 - Assertio Holdings, Inc. (0001808665) (Issuer)

    2/20/26 6:00:13 PM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease

    ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to enzyme replacement therapy MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (OTC:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for rare and neurologic diseases, today announced that it has entered into an exclusive worldwide license agreement with Duke University for patents and know-how pertaining to ATX-04 (clenbuterol), a well-characterized small-molecule β2-adrenergic agonist, in clinical development for the treatment of Pompe disease. Pompe d

    2/23/26 8:00:00 AM ET
    $ATXI
    $FBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Asana Now Available in the AWS Middle East (UAE) Region to Support Enterprise and Government Customers with Local Data Residency

    AI-powered work management platform now available with local data hosting and low-latency Asana, Inc. (NYSE:ASAN), a leading work management platform for human + AI collaboration, is now available in the AWS Middle East (UAE) Region. Asana is one of the first enterprise collaborative work management platforms to offer its services on AWS Marketplace. Its availability in the AWS Middle East (UAE) Region can help regulated and public sector organizations address data residency preferences. AI is accelerating how work gets done, but adoption depends on a strong foundation of trust, security, and governance. "We're seeing organizations across the Middle East modernize how they work—and

    2/22/26 11:00:00 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    JD.com to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026

    BEIJING, Feb. 20, 2026 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited fourth quarter and full year 2025 financial results on Thursday, March 5, 2026, before the U.S. market opens. JD.com's management will hold a conference call at 7:00 am, Eastern Time on March 5, 2026, (8:00 pm, Beijing/Hong Kong Time on March 5, 2026) to discuss the fourth quarter and full year 2025 financial results. Please register in advance of the conference using the link provided below and dial in 15 minutes prior to the call, using participa

    2/20/26 5:00:00 AM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Finance Op and Tech Schatz Scott bought $6,478 worth of shares (980 units at $6.61), increasing direct ownership by 2% to 58,051 units (SEC Form 4)

    4 - Townsquare Media, Inc. (0001499832) (Issuer)

    2/4/26 4:51:27 PM ET
    $TSQ
    Broadcasting
    Consumer Discretionary

    SVP, Product Dev. & Sourcing Schlecht Richard W bought $62,394 worth of Class B Common Stock (28,554 units at $2.19), increasing direct ownership by 9% to 352,233 units (SEC Form 4)

    4 - DULUTH HOLDINGS INC. (0001649744) (Issuer)

    12/29/25 4:20:34 PM ET
    $DLTH
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Officer Bouthillette Max bought $27,555 worth of shares (16,500 units at $1.67), increasing direct ownership by 13% to 142,865 units (SEC Form 4)

    4 - KLX Energy Services Holdings, Inc. (0001738827) (Issuer)

    12/16/25 5:31:04 PM ET
    $KLXE
    Oilfield Services/Equipment
    Energy

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Etsy upgraded by Barclays with a new price target

    Barclays upgraded Etsy from Equal Weight to Overweight and set a new price target of $72.00

    2/20/26 8:19:45 AM ET
    $ETSY
    Real Estate

    Asana upgraded by Citigroup with a new price target

    Citigroup upgraded Asana from Neutral to Buy and set a new price target of $16.00

    1/15/26 8:27:19 AM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    Analyst initiated coverage on Fulcrum Therapeutics with a new price target

    Analyst initiated coverage of Fulcrum Therapeutics with a rating of Overweight and set a new price target of $20.00

    1/12/26 8:13:43 AM ET
    $FULC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    SEC Filings

    View All

    Avenue Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

    2/23/26 4:06:15 PM ET
    $ATXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by JD.com Inc.

    6-K - JD.com, Inc. (0001549802) (Filer)

    2/20/26 6:01:57 AM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 10-K filed by Etsy Inc.

    10-K - ETSY INC (0001370637) (Filer)

    2/19/26 8:17:41 AM ET
    $ETSY
    Real Estate

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Financials

    Live finance-specific insights

    View All

    JD.com to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026

    BEIJING, Feb. 20, 2026 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited fourth quarter and full year 2025 financial results on Thursday, March 5, 2026, before the U.S. market opens. JD.com's management will hold a conference call at 7:00 am, Eastern Time on March 5, 2026, (8:00 pm, Beijing/Hong Kong Time on March 5, 2026) to discuss the fourth quarter and full year 2025 financial results. Please register in advance of the conference using the link provided below and dial in 15 minutes prior to the call, using participa

    2/20/26 5:00:00 AM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    Arhaus to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    BOSTON HEIGHTS, Ohio, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omnichannel retailer of premium artisan-crafted home furnishings, will release its fourth quarter and full year 2025 results on Thursday, February 26, 2026, before the stock market opens, followed by a conference call to review the Company's financial and operational results at 8:30 a.m. Eastern Time. A live webcast will be available at ir.arhaus.com. To participate in the live call, dial:U.S. Toll-Free: (877) 407-3982International: 1 (201) 493-6780Conference ID: 13748994 A telephone replay will be available for one week at:U.S. Toll-Free: 1-844-5

    2/19/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights

    CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 26, 2026, prior to the open of financial markets. Akebia will host a conference call on Thursday, February 26, 2026, at 8:00 a.m. EST to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time. A

    2/19/26 8:00:00 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Leadership Updates

    Live Leadership Updates

    View All

    Arhaus Appoints Michael Rengel as Chief Merchandising Officer

    BOSTON HEIGHTS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ:ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, announced that Michael Rengel has been appointed Chief Merchandising Officer, effective February 23, 2026. In this role, Michael will lead Arhaus' merchandising and product strategy across furniture and décor categories, supporting the Company's continued focus on assortment differentiation, product leadership, and disciplined growth. Michael will report to John Reed, Founder and Chief Executive Officer, and will oversee Product Development and Merchandising. Michael brings more tha

    2/12/26 4:01:00 PM ET
    $ARHS
    Other Specialty Stores
    Consumer Discretionary

    Build-A-Bear Workshop, Inc. Names James A. Goldman to Board of Directors

    Build-A-Bear Workshop, Inc. (NYSE:BBW) is pleased to announce the appointment of James A. Goldman to its Board of Directors, effective immediately. "After conducting an extensive search, we are pleased to welcome Mr. Goldman to our Board of Directors. We are confident that Mr. Goldman's extensive experience in leading successful global retail and branded consumer companies will enable him to make an immediate contribution as we look to accelerate our long-term strategic initiatives and continue to create value for our shareholders," said Craig Leavitt, Non-Executive Chairman of the Board. James A. Goldman has served on the Board of Directors of Domino's Pizza, Inc., a global restaurant

    2/10/26 4:05:00 PM ET
    $BBW
    Recreational Games/Products/Toys
    Consumer Discretionary

    Holley Performance Brands Appoints Del Bohlman as Vice President, Safety & Racing Division

    BOWLING GREEN, Ky., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE:HLLY), a leader in automotive aftermarket performance solutions, today announced the appointment of Del Bohlman as vice president of its Safety & Racing Division, effective Jan. 1, 2026. Bohlman succeeds Brian Appelgate, who is retiring after a distinguished four-decade career in the performance automotive industry. Bohlman brings more than 20 years of global leadership experience in the powersports and performance sectors, most recently as CEO of Dealer Rocket LLC and previously in senior roles at Bombardier Recreational Products (BRP). At BRP, Bohlman led global services, parts, accessories and garment

    1/20/26 8:30:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Duluth Holdings Inc.

    SC 13G/A - DULUTH HOLDINGS INC. (0001649744) (Subject)

    12/2/24 5:39:09 PM ET
    $DLTH
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AKBA
    $ARHS
    $ASAN
    $ASRT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at Stabilis Solutions Inc. on Jun 7 Indicate?

    Recently, on June 7, 2024, a notable insider purchase occurred at Stabilis Solutions Inc., as reported in a Form 4 filing by Puhala Andrew Lewis. Mr. Lewis purchased $4,150 worth of shares, acquiring 1,000 units at $4.15 per share. This transaction increased his direct ownership by 3% to 33,618 units. Insider transactions such as this one can provide valuable insights for investors, signaling confidence or positive sentiment from those within the company. Examining the historical insider transactions at Stabilis Solutions Inc., several interesting patterns emerge. In a previous Form 4 filed on May 2, 2023, Puhala Andrew Lewis initiated his ownership stake. This was followed by filings from

    6/10/24 12:45:26 AM ET
    $SLNG
    Oil/Gas Transmission
    Utilities